Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 24903792)

1.

Outbreak of pyrazinamide-monoresistant tuberculosis identified using genotype cluster and social media analysis.

Thomas TA, Heysell SK, Houpt ER, Moore JL, Keller SJ.

Int J Tuberc Lung Dis. 2014 May;18(5):552-8. doi: 10.5588/ijtld.13.0663.

2.

Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States.

Hannan MM, Desmond EP, Morlock GP, Mazurek GH, Crawford JT.

J Clin Microbiol. 2001 Feb;39(2):647-50.

3.

pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.

Cheng SJ, Thibert L, Sanchez T, Heifets L, Zhang Y.

Antimicrob Agents Chemother. 2000 Mar;44(3):528-32.

4.

Characterisation of pyrazinamide-resistant Mycobacterium tuberculosis strains isolated in Poland and Germany.

Napiórkowska A, Rüsch-Gerdes S, Hillemann D, Richter E, Augustynowicz-Kopeć E.

Int J Tuberc Lung Dis. 2014 Apr;18(4):454-60. doi: 10.5588/ijtld.13.0457.

PMID:
24670702
5.

Pyrazinamide resistance, Mycobacterium tuberculosis lineage and treatment outcomes in San Francisco, California.

Budzik JM, Jarlsberg LG, Higashi J, Grinsdale J, Hopewell PC, Kato-Maeda M, Nahid P.

PLoS One. 2014 Apr 23;9(4):e95645. doi: 10.1371/journal.pone.0095645. eCollection 2014.

6.

Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999-2009.

Kurbatova EV, Cavanaugh JS, Dalton T, S Click E, Cegielski JP.

Clin Infect Dis. 2013 Oct;57(8):1081-93. doi: 10.1093/cid/cit452. Epub 2013 Jul 9.

7.

Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing.

Shenai S, Rodrigues C, Sadani M, Sukhadia N, Mehta A.

Indian J Tuberc. 2009 Apr;56(2):82-90.

PMID:
19810590
8.

Spoligotype-based comparative population structure analysis of multidrug-resistant and isoniazid-monoresistant Mycobacterium tuberculosis complex clinical isolates in Poland.

Jagielski T, Augustynowicz-Kopec E, Zozio T, Rastogi N, Zwolska Z.

J Clin Microbiol. 2010 Nov;48(11):3899-909. doi: 10.1128/JCM.00572-10. Epub 2010 Sep 1.

9.

Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: a longitudinal molecular epidemiological study.

Roetzer A, Diel R, Kohl TA, Rückert C, Nübel U, Blom J, Wirth T, Jaenicke S, Schuback S, Rüsch-Gerdes S, Supply P, Kalinowski J, Niemann S.

PLoS Med. 2013;10(2):e1001387. doi: 10.1371/journal.pmed.1001387. Epub 2013 Feb 12.

10.

Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran.

Doustdar F, Khosravi AD, Farnia P.

Microb Drug Resist. 2009 Dec;15(4):251-6. doi: 10.1089/mdr.2009.0066.

PMID:
19857130
11.

Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India.

Muthaiah M, Jagadeesan S, Ayalusamy N, Sreenivasan M, Prabhu SS, Muthuraj U, Senthilkumar K, Veerappan S.

Int J Mol Sci. 2010 Jul 7;11(7):2670-80. doi: 10.3390/ijms11072670.

12.

Transmission of specific genotype streptomycin resistant strains of Mycobacterium tuberculosis in the Tokyo Metropolitan Area in Japan.

Ohkado A, Murase Y, Mori M, Hasegawa N, Otsuka G, Nagamine M, Maeda H, Uchimura K, Ohmori M, Yamada N, Maeda S, Kato S, Mori T, Ishikawa N.

BMC Infect Dis. 2009 Aug 26;9:138. doi: 10.1186/1471-2334-9-138. Erratum in: BMC Infect Dis. 2010;10:79.

13.

Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience.

Hoffner S, Angeby K, Sturegård E, Jönsson B, Johansson A, Sellin M, Werngren J.

Int J Tuberc Lung Dis. 2013 Nov;17(11):1486-90. doi: 10.5588/ijtld.13.0195.

PMID:
24125455
14.

[Pyrazinamide monoresistant Mycobacterium tuberculosis in Manisa region, Turkey].

Ozkütük N, Ecemiş T, Sürücüoğlu S.

Mikrobiyol Bul. 2008 Oct;42(4):585-90. Turkish.

PMID:
19149079
15.
17.

Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.

Jonmalung J, Prammananan T, Leechawengwongs M, Chaiprasert A.

BMC Microbiol. 2010 Aug 20;10:223. doi: 10.1186/1471-2180-10-223. Erratum in: BMC Microbiol. 2010;10:278.

18.

Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis.

Pholwat S, Stroup S, Gratz J, Trangan V, Foongladda S, Kumburu H, Juma SP, Kibiki G, Houpt E.

Tuberculosis (Edinb). 2014 Jan;94(1):20-5. doi: 10.1016/j.tube.2013.10.006. Epub 2013 Nov 1.

19.

Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients.

Louw GE, Warren RM, Donald PR, Murray MB, Bosman M, Van Helden PD, Young DB, Victor TC.

Int J Tuberc Lung Dis. 2006 Jul;10(7):802-7.

PMID:
16848344
20.

Widespread pyrazinamide-resistant Mycobacterium tuberculosis family in a low-incidence setting.

Nguyen D, Brassard P, Westley J, Thibert L, Proulx M, Henry K, Schwartzman K, Menzies D, Behr MA.

J Clin Microbiol. 2003 Jul;41(7):2878-83.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk